Literature DB >> 31563153

Keratinocyte cadherin desmoglein 1 controls melanocyte behavior through paracrine signaling.

Christopher R Arnette1, Quinn R Roth-Carter1, Jennifer L Koetsier1, Joshua A Broussard1,2, Hope E Burks1, Kathleen Cheng3, Christine Amadi4, Pedram Gerami1,2,4,5, Jodi L Johnson1,2,4, Kathleen J Green1,2,4.   

Abstract

The epidermis is the first line of defense against ultraviolet (UV) light from the sun. Keratinocytes and melanocytes respond to UV exposure by eliciting a tanning response dependent in part on paracrine signaling, but how keratinocyte:melanocyte communication is regulated during this response remains understudied. Here, we uncover a surprising new function for the keratinocyte-specific cell-cell adhesion molecule desmoglein 1 (Dsg1) in regulating keratinocyte:melanocyte paracrine signaling to promote the tanning response in the absence of UV exposure. Melanocytes within Dsg1-silenced human skin equivalents exhibited increased pigmentation and altered dendrite morphology, phenotypes which were confirmed in 2D culture using conditioned media from Dsg1-silenced keratinocytes. Dsg1-silenced keratinocytes increased melanocyte-stimulating hormone precursor (Pomc) and cytokine mRNA. Melanocytes cultured in media conditioned by Dsg1-silenced keratinocytes increased Mitf and Tyrp1 mRNA, TYRP1 protein, and melanin production and secretion. Melanocytes in Dsg1-silenced skin equivalents mislocalized suprabasally, reminiscent of early melanoma pagetoid behavior. Together with our previous report that UV reduces Dsg1 expression, these data support a role for Dsg1 in controlling keratinocyte:melanocyte paracrine communication and raise the possibility that a Dsg1-deficient niche contributes to pagetoid behavior, such as occurs in early melanoma development.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  desmosomes; environment; keratinocytes; melanocytes; melanoma; skin; sunlight

Mesh:

Substances:

Year:  2019        PMID: 31563153      PMCID: PMC7028503          DOI: 10.1111/pcmr.12826

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  52 in total

1.  Epidermal Desmoglein 1 Expression Is Reduced in Kidney Transplant Recipients Compared with Immunocompetent Patients.

Authors:  Jodi L Johnson; Paul Hoover; Borko D Jovanovic; Kathleen J Green; John J Friedewald; June K Robinson
Journal:  J Invest Dermatol       Date:  2016-06-11       Impact factor: 8.551

Review 2.  Macroenvironment-gene-microenvironment interactions in ultraviolet radiation-induced melanomagenesis.

Authors:  Xuan Mo; Sarah Preston; M Raza Zaidi
Journal:  Adv Cancer Res       Date:  2019-04-23       Impact factor: 6.242

3.  α-Melanocyte stimulating hormone (MSH) and prostaglandin E2 (PGE2) drive melanosome transfer by promoting filopodia delivery and shedding spheroid granules: Evidences from atomic force microscopy observation.

Authors:  Hui-Jun Ma; Hui-Yong Ma; Yang Yang; Peng-Cheng Li; Shao-Xia Zi; Chi-Yu Jia; Rong Chen
Journal:  J Dermatol Sci       Date:  2014-09-30       Impact factor: 4.563

4.  Variation in melanin content and composition in type V and VI photoexposed and photoprotected human skin: the dominant role of DHI.

Authors:  S Alaluf; A Heath; N Carter; D Atkins; H Mahalingam; K Barrett; R Kolb; N Smit
Journal:  Pigment Cell Res       Date:  2001-10

5.  Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation.

Authors:  Robert M Harmon; Cory L Simpson; Jodi L Johnson; Jennifer L Koetsier; Adi D Dubash; Nicole A Najor; Ofer Sarig; Eli Sprecher; Kathleen J Green
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

Review 6.  The good and the bad of chemokines/chemokine receptors in melanoma.

Authors:  Ann Richmond; Jinming Yang; Yingjun Su
Journal:  Pigment Cell Melanoma Res       Date:  2009-02-14       Impact factor: 4.693

Review 7.  MITF in melanoma: mechanisms behind its expression and activity.

Authors:  Mariusz L Hartman; Malgorzata Czyz
Journal:  Cell Mol Life Sci       Date:  2014-11-30       Impact factor: 9.261

8.  The epidermal polarity protein Par3 is a non-cell autonomous suppressor of malignant melanoma.

Authors:  Melina Mescher; Peter Jeong; Sina K Knapp; Matthias Rübsam; Michael Saynisch; Marina Kranen; Jennifer Landsberg; Max Schlaak; Cornelia Mauch; Thomas Tüting; Carien M Niessen; Sandra Iden
Journal:  J Exp Med       Date:  2017-01-17       Impact factor: 14.307

9.  Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis.

Authors:  Spiro Getsios; Cory L Simpson; Shin-ichiro Kojima; Robert Harmon; Linda J Sheu; Rachel L Dusek; Mona Cornwell; Kathleen J Green
Journal:  J Cell Biol       Date:  2009-06-22       Impact factor: 10.539

10.  Defining MC1R regulation in human melanocytes by its agonist α-melanocortin and antagonists agouti signaling protein and β-defensin 3.

Authors:  Viki B Swope; Joshua A Jameson; Kevin L McFarland; Dorothy M Supp; William E Miller; Dennis W McGraw; Mira A Patel; Matthew A Nix; Glenn L Millhauser; George F Babcock; Zalfa A Abdel-Malek
Journal:  J Invest Dermatol       Date:  2012-05-10       Impact factor: 8.551

View more
  11 in total

1.  Tracing the Evolutionary Origin of Desmosomes.

Authors:  Kathleen J Green; Quinn Roth-Carter; Carien M Niessen; Scott A Nichols
Journal:  Curr Biol       Date:  2020-05-18       Impact factor: 10.834

2.  Comprehensive analysis and identification of key genes and signaling pathways in the occurrence and metastasis of cutaneous melanoma.

Authors:  Hanying Dai; Lihuang Guo; Mingyue Lin; Zhenbo Cheng; Jiancheng Li; Jinxia Tang; Xisha Huan; Yue Huang; Keqian Xu
Journal:  PeerJ       Date:  2020-11-19       Impact factor: 2.984

Review 3.  Desmosomal Cadherins in Health and Disease.

Authors:  Marihan Hegazy; Abbey L Perl; Sophia A Svoboda; Kathleen J Green
Journal:  Annu Rev Pathol       Date:  2021-08-23       Impact factor: 23.472

4.  Desmoglein 2 regulates cardiogenesis by restricting hematopoiesis in the developing murine heart.

Authors:  Hoda Moazzen; Kateryna Venger; Sebastian Kant; Rudolf E Leube; Claudia A Krusche
Journal:  Sci Rep       Date:  2021-11-04       Impact factor: 4.379

5.  Translational implications of Th17-skewed inflammation due to genetic deficiency of a cadherin stress sensor.

Authors:  Lisa M Godsel; Quinn R Roth-Carter; Jennifer L Koetsier; Lam C Tsoi; Amber L Huffine; Joshua A Broussard; Gillian N Fitz; Sarah M Lloyd; Junghun Kweon; Hope E Burks; Marihan Hegazy; Saki Amagai; Paul W Harms; Xianying Xing; Joseph Kirma; Jodi L Johnson; Gloria Urciuoli; Lynn T Doglio; William R Swindell; Rajeshwar Awatramani; Eli Sprecher; Xiaomin Bao; Eran Cohen-Barak; Caterina Missero; Johann E Gudjonsson; Kathleen J Green
Journal:  J Clin Invest       Date:  2022-02-01       Impact factor: 14.808

Review 6.  Neuroendocrine Factors in Melanoma Pathogenesis.

Authors:  Cristian Scheau; Carmen Draghici; Mihaela Adriana Ilie; Mihai Lupu; Iulia Solomon; Mircea Tampa; Simona Roxana Georgescu; Ana Caruntu; Carolina Constantin; Monica Neagu; Constantin Caruntu
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

7.  Desmosomes polarize and integrate chemical and mechanical signaling to govern epidermal tissue form and function.

Authors:  Joshua A Broussard; Jennifer L Koetsier; Marihan Hegazy; Kathleen J Green
Journal:  Curr Biol       Date:  2021-06-08       Impact factor: 10.900

Review 8.  Cell Adhesion Molecules in Plasticity and Metastasis.

Authors:  Jessica A Smart; Julia E Oleksak; Edward J Hartsough
Journal:  Mol Cancer Res       Date:  2020-10-01       Impact factor: 6.333

Review 9.  Desmosomes:  Essential contributors to an integrated intercellular junction network.

Authors:  Kathleen J Green; Avinash Jaiganesh; Joshua A Broussard
Journal:  F1000Res       Date:  2019-12-30

Review 10.  The Interplay between Tumour Microenvironment Components in Malignant Melanoma.

Authors:  Cornelia Amalinei; Adriana Grigoraș; Ludmila Lozneanu; Irina-Draga Căruntu; Simona-Eliza Giușcă; Raluca Anca Balan
Journal:  Medicina (Kaunas)       Date:  2022-03-02       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.